What Happened to the Flu and RSV?
Wash your hands. Cover your nose. It’s familiar advice, but in the wake of a global pandemic, more people seem to be following it.
“Most Favored Nation” Doesn’t Favor Patients
A new federal experiment could force tens of thousands of patients off of their medication in 2021.
Pregnant Women’s New Ally
Before this day is over, two women in the U.S. will die in childbirth or as the result of a pregnancy complication.
Why Finding a Doctor Just Got Harder
This year may find many patients searching for a new doctor, but not because they were dissatisfied with the one they had.
Does Patient Input Fall on Deaf Ears?
When it comes to incorporating patients into decisions about medication and value, the United States just isn’t making the grade.
Screen Time, Delayed Care Endanger Eyesight
From work to school, book clubs to coffee dates, people are online more than ever before.
2020 in Review: Seven Policy Issues Affecting Patient Access
COVID-19 dominated health care discussions this year, but it wasn’t the only topic that led to policy debate. Here’s a look back at seven issues that shaped health policy in 2020.
National Policy & Advocacy Summit on Biologics
The fifth annual National Policy & Advocacy Summit on Biologics brought together health care providers, policy experts, patient advocates and other stakeholders. The event explored how sound public policies can facilitate the safe use of biologics in patient-centered care. This year’s event, held virtually, examined issues such as: What the 2020 election means for health […]
Heart Doctors Want ICER to Get Real
When you or someone you love has a cardiovascular event, life gets real – fast.
How ICER Underestimates High Cholesterol
The Institute for Clinical and Economic Review claims that new medications for high cholesterol aren’t worth their cost. The economists overlook the needs of high-risk patients – and underestimate the impact of high cholesterol. View Graphic
